2019Äê6ÔÂ22ÈÕ-23ÈÕ£¬µÚÁù½ì·Ç±àÂëRNAºÍ±í¹ÛÒÅ´«Ñ§Ñо¿¾­Ñé½»Á÷»áÔÚ¹ãÖÝôä´äÏ£¶û¶Ù¾Æµê˳ÀûÕÙ¿ª£¬±¾½ì»áÒéÒÔ¡°Ð·¢ÏÖ • ̽Ë÷ÉúÃüµ÷¿ØµÄ°ÂÃØ¡±ÎªÖ÷Ì⣬ÑûÇëÁË20λ¶àλ±¾ÁìÓòµÄ׿Խ¿ÆÑ§¼Ò×÷Á˾«²Ê±¨¸æ£¬À´×ÔÈ«¹ú¸÷´ó¸ßУ¡¢¿ÆÑÐÔºËù¡¢Ò½Ôº¡¢ÆóÒµ¡¢Ã½Ìå½ü300È˲λᣬΪÆÚÁ½ÌìµÄѧÊõ½»Á÷ÔÚÕóÕóÕÆÉùºÍ»¥¶¯ÖÐÍêÃÀÂäÄ»£¡


µÚÁù½ì·Ç±àÂëRNAÓë±í¹ÛÒÅ´«Ñ§½»Á÷»áÏÖ³¡Ê¢¿ö


±¾½ìÑݽ²¼Î±öÓëÖ÷³Ð°ì·½¹¤×÷ÈËÔ±ºÏÓ°

Áù½ì½»Á÷»á´ó»áÒéÌâ¾Û½¹·Ç±àÂëRNAºÍҽѧÑо¿½øÕ¹£¬ÍâÃÚÌå¡¢±í¹Ûµ÷¿Ø¼°ÉúÎï±êÖ¾ÎRNAiÓëCRISpRÑо¿Ç°Ñؼ¼Êõ£¬´óÊý¾ÝÓëÉúÎïÐÅϢѧ¡£¼Î±öÃÇÒÔ½üÆÚ·¢±íµÄÔ­´´ÐÔÓëÍ»ÆÆÐÔ·¢ÏÖÒÔ¼°Ð¼¼Êõ£¬·ÖÏíÁËʵÓÃÇ°ÑØµÄÑо¿¾­ÑéºÍ¿ÎÌâÉè¼ÆË¼Â·£¬±¨¸æÄÚÈݺ­¸ÇÁËÐÄѪ¹Ü¼²²¡¡¢Ë¥ÀÏ¡¢»ùÒòÖÎÁÆ¡¢ÍâÃÚÌå¡¢·Ç±àÂëRNA¡¢CRISpR¡¢µ¥Ï¸°û²âÐò¡¢m6A¡¢RNA½áºÏµ°°×¡¢±í¹Ûת¼×é/±í¹Û»ùÒò×é¡¢Ö²Îï±í¹ÛÐÞÊΡ¢Êý¾ÝÍÚ¾òÓë·ÖÎöµÈ·á¸»µÄÄÚÈÝ£¬¸É»õÂúÂú£¡

»áÒ鿪ĻÖ´Ç


½»Á÷»á×ܸºÔðÈË
Èñ²©ÉúÎïÊг¡×ܼಷ¼Ì¹úÏÈÉúÖ¿ªÄ»´Ê

Èñ²©ÉúÎïÊг¡×ܼಷ¼Ì¹úÏÈÉú´ú±í´ó»á³Ð°ì·½Ö¿ªÄ»´Ê£¬½ÒÄ»½ñÄê´ó»áÖ÷Ì⡪¡ª¡°Ð·¢Ï֕̽Ë÷ÉúÃüµ÷¿ØµÄ°ÂÃØ¡±£¬ÏòÓë»áÕßÂ¡ÖØ½éÉܵ½³¡¼Î±ö£¬²¢ÏòËùÓÐÏÖ³¡×¨¼Ò¡¢Ñ§Õß¡¢Ñо¿Éú¡¢ÔÞÖúÉÌÒÔ¼°ºÏ×÷ýÌå±í´ïÁË×î³ÏÖ¿µÄ»¶Ó­ºÍÖÔÐĵĸÐл£¬¸Ðл´ó¼Ò¹²Í¬Ð¯ÊÖ´´ÔìÁËÕâÒ»Öйú·Ç±àÂëRNAºÍ±í¹ÛÒÅ´«Ñ§µÄÄê¶ÈÊ¢»á¡£

¼Î±ö¾«²Ê±¨¸æ»Ø·Å¡¾6ÔÂ22ÈÕ•ÏÖ³¡¡¿


Öйú¿ÆÑ§ÔºSportÑо¿ËùʩһÑо¿Ô±

¿ªÄ»Ö´Ǻó£¬Öйú¿ÆÑ§ÔºÇàÄ괴дٽø»áÀíÊÂ»á¸±ÃØÊ鳤¡¢Öйú¿ÆÑ§ÔºSportÑо¿ËùʩһÑо¿Ô±´ú±íÖ÷°ì·½¡°µãȼÁË¡±¡¶ÐÂʱ´ú£¬ÇàÄêѧÕß´´ÐÂÖ®ÃΡ·¡£Ê×ÏȽéÉÜÁËÇàÄ괴дٽø»áµÄ»ù±¾Çé¿ö¡¢×éÖ¯¼Ü¹¹¡¢º­¸ÇµÄѧ¿Æ¡¢»áÔ±·Ö²¼Çé¿öÒÔ¼°Ïà¹ØÕþ²ßµÈ£¬²¢·ÖÏíÁËÇà´Ù»á³ÉÔ±ÔÚ¸÷¸ö¿ÆÑ§ÁìÓòÈ¡µÃµÄÖØ´ó¿ÆÑ§Í»ÆÆ¡£×îºóºôÓõ¸ü¶àÇàÄê¿ÆÑ§¼ÒÄܹ»¼ÓÈëÇà´Ù»á£¬ÔÚ¿ÆÑ§Ñо¿¹ý³ÌÖÐÄܹ»¹²Í¬Ð­×÷£¬ÓÂÓÚ´´Ð¡¢¼á³Ö´´Ð¡£


ÖпÆÔºÉú»¯Ï¸°ûËù
ϸ°ûÉúÎïѧ¹ú¼ÒÖØµãʵÑéÊÒÖ÷ÈÎÀî¾¢ËÉÑо¿Ô±

×÷Ϊ±¾½ì½»Á÷»áµÚһ뱨¸æ¼Î±ö£¬ÖпÆÔºÉú»¯Ï¸°ûËù¡¢Ï¸°ûÉúÎïѧ¹ú¼ÒÖØµãʵÑéÊÒÖ÷ÈÎÀî¾¢ËÉÑо¿Ô±×÷ÁËΪ¡¶»ùÒò×é±êÇ©¼Æ»®£¨Genome Tagging project£¬GTp£©: tag every protein in mice through ¡°artificial spermatids¡±¡·µÄ¾«²Ê±¨¸æ¡£¿ª³¡¾ÍΪ´ó¼ÒÉú¶¯Ï¸Öµؽ²ÊöÁË¡°ÈËÔ쾫×Óϸ°û¡±½éµ¼µÄ°ë¿Ë¡¼¼Êõ£¬²¢½éÉÜÁËÐí¶àÓÃÓÚÄ£ÄâÈËÀà¶à»ùÒò½éµ¼µÄ¸´ÔÓ¼²²¡µÄСÊóÄ£ÐÍ£¬ÎªÑо¿ÈËÀ༲²¡ºÍ·¢Óý£¬ÒÔ¼°¿ªÕ¹µ°°×Öʹ¦ÄܵÄÔÚÌ塢ʵʱ¡¢¶¯Ì¬¡¢ÍøÂçÑо¿ÌṩÁËеÄÊֶΡ£Í¬Ê±ÎªÊµÏÖÈ«»ùÒò×éµ°°×ÖʱêÇ©¼Æ»®£¨genome tagging project, GTp£©¾ßÓÐÖÁ¹ØÖØÒªµÄ×÷Óá£


¸´µ©´óѧÉúÎïҽѧÑо¿ÔºÓÚÎÄÇ¿½ÌÊÚ

µÚ¶þ¸ö´ó»á±¨¸æÊÇÓÉ****¡¢¸´µ©´óѧÉúÎïҽѧÑо¿Ôº¸ß¼¶pIÓÚÎÄÇ¿½ÌÊÚ´øÀ´µÄ¡¶miRNA in Nucleus£¬ A New Network of NamiRNAs and Enhancers¡·¡£Ê×ÏÈÓÚ½ÌÊÚÌá³öÁËÏÖ½ñmiRNAÑо¿µÄ¡°Îå´óÃÕÍÅ¡±£¬²¢Ö¸³ömiRNAÓëÔöÇ¿×ÓÈçÓ°ËæÐΣ¬´Ó¶øÌá³öÁËNamiRNA-ÔöÇ¿×Ó-»ùÒò¼¤»îÐÂģʽ£¬½Ó×Å·ÖÏíÁËNamiRNAsÑо¿µÄ¡°ËÄ´óвßÂÔ¡±ÒÔ¼°¡°Èý´óÑо¿ÐÂ˼·¡±£¨ÌÔ½ðÐÍÑо¿¡¢¼ñ©ÐÍÑо¿¡¢¿ªÍØÐÍÑо¿£©£¬×îºóÖ¸³öNamiRNAÊÇmiRNAÑо¿µÄ2.0ʱ´ú¡£


±±¾©´óѧÉúÃü¿ÆÑ§Ñ§ÔºÎºÎÄʤÑо¿Ô±

±±¾©´óѧÉúÃü¿ÆÑ§Ñ§ÔºÎºÎÄʤÑо¿Ô±×÷ΪµÚÈýλ´ó»á±¨¸æ¼Î±ö£¬·ÖÏíÁËÆä¿ÎÌâ×é½üÆÚ·¢±íÔÚNature×Ó¿¯µÄÖØÒªÑо¿³É¹û£¬Îª´ó¼Ò½éÉÜÁËÒ»ÖÖÈ«»ùÒò×éɸѡlncRNAµÄCRISpRз½·¨£¬Í¨¹ý¹¹½¨¼ô½Ó°ÐÏòsgRNAµÄÈ«»ùÒò×éÎĿ⣬¿É´ó´óÌá¸ßHTSµÄЧÂʺÍÊý¾ÝÖÊÁ¿£¬´Ó¶ø¶Ô¹¦ÄÜÐÔlncRNAs½øÐÐÈ«»ùÒò×éɸÑ¡£»Í¬Ê±£¬»¹½éÉÜÁËÒ»ÖÖÒÔµ¥°±»ùËá·Ö±æÂÊ»æÖÆÄ¿µÄµ°°×Öʹ¦ÄÜλµãµÄз½·¨¡£Õ⽫ÓÐÖúÓÚÔÚ¸÷ÖÖ»·¾³ÖÐ׼ȷ¡¢¿ìËٵؼø¶¨¹¦ÄÜ»ùÒò×éÔª¼þ£¬²¢½øÒ»²½À©Õ¹ÁËÓÃÓÚ²¸È鶯ÎïÒÅ´«Ñ§µÄCRISpRÑо¿¹¤¾ß¡£


±±¾©´óѧ·Ö×ÓҽѧÑо¿ËùÍôÑôÃ÷Ñо¿Ô±

±±¾©´óѧ·Ö×ÓҽѧÑо¿ËùÍôÑôÃ÷Ñо¿Ô±Éú¶¯ÓÐȤµÄΪ¸÷λ²Î»áÕß´øÀ´Á˹ØÓÚmiRNAÓÕµ¼µÄCRISpR-Cas9ϵͳ¿É×÷ΪmiRNA´«¸ÐÆ÷ºÍϸ°ûÀàÐÍÌØÒìÐÔ»ùÒò×éµ÷½Ú¹¤¾ßµÄ¾«²Ê±¨¸æ¡£Íô²©Ê¿¿ÎÌâ×é´´ÐÂÐÔµØÀûÓÃmiRNA½éµ¼µÄsgRNAÊͷŲßÂÔºÍdCas9-VpRÇý¶¯×ª»ùÒòRFp±í´ï£¬¹¹½¨ÁË¿ÉÕæÊµ²âÁ¿Ï¸°ûˮƽÉϵÄmiRNA»îÐÔ£¬²¢¼à²â¸Éϸ°û·Ö»¯×´Ì¬µÄmiRNA´«¸ÐÆ÷¡£ÏêϸµØ²ûÃ÷Á˸ÃϵͳÓÃÓÚʵÏÖϸ°ûÀàÐÍÌØÒìÐÔ»ùÒò×éµ÷½ÚµÄ¹¤×÷Ô­Àí¡£


Î人´óѧҽѧÑо¿ÔºÒó껽ÌÊÚ

Î人´óѧҽѧÑо¿ÔºÒó껽ÌÊÚΪ´ó¼Ò´øÀ´ÁËÓÃÓÚ»ùÒòÖÎÁƵÄÌåÄÚ»ùÒò×é±à¼­µÄרÌⱨ¸æ¡£Òó½ÌÊÚÊ×ÏÈÖ¸³öÁË»ùÒò±à¼­¹¤¾ß-CRISpRϵͳÔÚÁÙ´²ÉÏÒÔ¼°ÆäËûÓ¦ÓÃÉϵľ޴óDZÁ¦£¬¼°ÆäÃæÁÙµÄ×î´óÄѵã-ÓÐЧµÍÍѰеÄÌåÄÚ´«Êä¡£²¢½áºÏÆä¶àÄêÀ´µÄ»ùÒò±à¼­ºÍºËËáÒ©Îï´«ÊäÑо¿¹¤×÷£¬·ÖÏíÁËÈçºÎÓ¦Ó÷Ö×ÓÉúÎïѧ¡¢ÉúÎïÐÅϢѧ¡¢²¡¶¾Ñ§¡¢Ä£Ê½¶¯Îï¡¢ÄÉÃ׿ÆÑ§ºÍ»¯Ñ§µÄÊÖ¶ÎÀ´½â¾ö´ËÄѵ㣬ʹ¸÷λ²Î»áÕßÊÜÒæ·Ëdz¡£


ÉϺ£½»Í¨´óѧ/¹ãÖÝÒ½¿Æ´óѧÎâÇ¿½ÌÊÚ

ÉϺ£½»Í¨´óѧ/¹ãÖÝÒ½¿Æ´óѧÎâÇ¿½ÌÊÚ×÷ÁËÌâΪ¡¶¾«×¼ÇÒ¿ÉÔ¤²âµÄCRISpR·Ç±àÂëÆ¬¶Î±à¼­½Òʾ³É´®¾øÔµ×ÓCTCFλµãµÄÈýά¼Ü¹¹¹æÂÉ¡·µÄרÌⱨ¸æ¡£²ûÊöÁËͨ¹ýDNAƬ¶Î±à¼­·¢Ïֳɴ®CTCFλµãÔÚÈýά»ùÒò×éÍØÆË¾øÔµ×Ӽܹ¹ÒÔ¼°¸´ÔÓ»ùÒò×鵥ϸ°ûÌØÒìÐÔµ÷¿ØµÄ¹æÂÉ¡£½ÒʾÁ˵¥¸öCBS£¨CTCF½áºÏλµã£©¾øÔµ×Ó¿ÉÈ·±£Êʵ±µÄÔöÇ¿×Ó¾øÔµºÍÆô¶¯×Ó¼¤»î£¬¶ø´®ÁÐCBS¾øÔµ×Ó¾ö¶¨ÁËÆ½ºâµÄÆô¶¯×ÓʹÓá£Ö¸³öÕâÒ»·¢ÏÖ¶ÔÍØÆË¾øÔµÌåÔÚÈýά»ùÒò×éÕÛµþºÍ·¢Óý»ùÒòµ÷¿ØÖеÄ×÷ÓþßÓÐÊ®·ÖÖØÒªµÄ×÷Óá£


Èñ²©ÉúÎï¿ÆÑзþÎñʵÑéÊÒ¸ºÔðÈËÐíÕòȺ²©Ê¿

Èñ²©ÉúÎï¿ÆÑзþÎñʵÑéÊÒ¸ºÔðÈËÐíÕòȺ²©Ê¿Îª´ó¼Ò´øÀ´Á˷DZàÂëRNAÑо¿¼¼ÊõÓëÆ½Ì¨µÄרÌâ¼¼Êõ±¨¸æ¡£Ö÷Òª´Ó¸ßÄÚº­Æ½Ì¨¡¢CRISpR-Cas9»ùÒò±à¼­¼¼Êõ²úÆ·ÒÔ¼°MeRIpʵÑé·þÎñÓë²úÆ·Èý·½ÃæÕ¹¿ª¡£Öصã½éÉÜÁËĿǰ¸ßÄÚº­Æ½Ì¨µÄÓ¦ÓÃÁìÓò¼°Æä¾Þ´óµÄÓÅÊÆ£¬²¢¾ÙÀý˵Ã÷Á˸ßÄÚº­Æ½Ì¨ÈçºÎ´îÅäsiRNA/miRNAÎÄ¿âÒÔ»ñµÃ¸ü¾ßÍ»ÆÆÐÔµÄÑо¿³É¹û¡£´ËÍ⣬»¹Öصã½éÉÜÁËÈñ²©ÖذõÍÆ³öµÄ»ùÓÚÈ«RNA (Cas9 mRNA + crRNA + tracrRNA)ÌåϵºÍRNp (Cas9 protein + crRNA + tracrRNA)ÌåϵµÄCRISpR-Cas9»ùÒò±à¼­Ð²úÆ·£¬·½±ã¡¢Ê¡Ê±¡¢¿É¿¿¡¢±à¼­Ð§Âʸߣ¬²¢¿ÉÌṩ±à¼­Ð§Âʱ£Ö¤Ì××°¼°ÊÛºó·þÎñ¡£


±±¾©´óѧ»¯Ñ§Óë·Ö×Ó¹¤³ÌѧԺ¼Ö¹ð·¼Ñо¿Ô±

±±¾©´óѧ»¯Ñ§Óë·Ö×Ó¹¤³ÌѧԺ¼Ö¹ð·¼Ñо¿Ô±Îª´ó¼Ò´øÀ´Á˼ì²âºÍ»æÖƱí¹Ûת¼×é±ê¼ÇµÄN6-¼×»ùÏÙÜÕµÄרÌⱨ¸æ¡£±¨¸æÖ¸³öÁËĿǰm6A¼ì²â·½·¨´æÔڵľÖÏÞÐÔ£¬Ïò²Î»áÕß½éÉÜÁËÆä¿ÎÌâ×鿪·¢µÄ2ÖÖÓÃÓÚ¼ì²âλµãÌØÒìÐÔµÄm6AºÍȫת¼µÄm6AλµãµÄй¤¾ß¡£ÆäÒ»ÊÇ»ùÓÚÑÓÉìºÍÁ¬½ÓµÄqpCRÀ©Ôö·½·¨£¬¿ÉÓÃÓÚµ¥¸ö»ùÒòÖÐm6AλÖõÄÎÞ·ÅÉäÐÔ±ê¼Ç¼ì²â£»Æä¶þÊÇÓÃÓÚ»æÖÆm6A¼×»ù»¯×éµÄÎÞ¿¹ÌåºÍ»¯Ñ§±ê¼Ç·½·¨¡£


Öйú¿ÆÑ§ÔºÉϺ£ÉúÎﻯѧÓëϸ°ûÉúÎïѧÑо¿Ëù
ÎâÁ¢¸ÕÑо¿Ô±

Öйú¿ÆÑ§ÔºÉϺ£ÉúÎﻯѧÓëϸ°ûÉúÎïѧÑо¿ËùÎâÁ¢¸ÕÑо¿Ô±ÔÚ´ó»á±¨¸æÖдø´ó¼ÒÒ»Æðͨ¹ýµ¥Ï¸°û²âÐò̽Ë÷СRNAÊÀ½ç¡£ÎâÁ¢¸Õ²©Ê¿Ê×ÏȽéÉÜÁËÆä¿ÎÌâ×鿪·¢µÄÒ»ÖÖÌØ±ðÊÊÓÃÓÚ¼ì²â·Ç³£µÍˮƽ±í´ïµÄСRNA·½·¨-CAS-seq£¬¿ÉÓÃÓÚ·ÖÎöÈËÀàºÍºï×Óµ¥¸öÂÑĸϸ°ûÖеĸ÷ÖÖСRNAs£¬»¹¿É¼ø¶¨ÐµÄ20nt piRNAÀà±ð£¬ÖØµã¹Ø×¢ÁËos-piRNAs (oocyte short piRNAs)µÄ¹¦Äܺͽø»¯¡£Ö¸³ö¸Ã·½·¨¿ÉΪÑо¿Á鳤ÀදÎïÂÑĸϸ°ûºÍÔçÆÚÅßÌ¥ÖÐСRNAµÄ¹¦Äܺͽø»¯ÌṩÓмÛÖµµÄÊý¾Ý¼¯¡£


Öйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿ËùÓáÑóÑо¿Ô±

Öйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿ËùÓáÑóÑо¿Ô±Îª´ó¼Ò´øÀ´ÁËÌâΪ¡¶A pandas complex adapted for piRNA-guided transposon silencing¡·µÄרÌⱨ¸æ¡£½éÉÜÁ˺ËÊä³öÒò×ÓdNxf2µÄÖÖÏµÌØÒìÐÔparalogueÓëpanoramixºÍdNxt1£¨p15£©Ò»Æð×÷ΪÈýÔª¸´ºÏÎïÆð×÷ÓÃÒÔÒÖÖÆ×ª×ù×Ó±í´ï¡£²ûÃ÷ÁËdNxf2µÄUBA½á¹¹ÓòÔÚpanoramix½áºÏºÍת×ù×Ó³ÁĬÖеĹؼü×÷Óá£ÈÏΪdNxf2×÷Ϊpandas£¨panoramix-dNxf2ÒÀÀµÐÔTAp³ÁĬ£©¸´ºÏÎÆä¿ÉµÖÏûµäÐ͵ÄRNAÊä³ö»úÖÆ£¨TAp/p15£©£¬²¢½«×ª×ù×ÓÏÞÖÆÔÚºËÖܱß¡£½ÒʾÁËpandas¸´ºÏÌåÊÊÓÃÓÚpiRNAÒýµ¼×ª×ù×Ó³ÁĬµÄ»úÖÆ¡£


¼Î±ö¾«²Ê±¨¸æ»Ø·Å¡¾6ÔÂ23ÈÕ•ÏÖ³¡¡¿


Öйú¿ÆÑ§ÔºÒÅ´«Óë·¢ÓýÉúÎïѧÑо¿Ëù
ÍõÐã½ÜÑо¿Ô±

´ó»áµÚ¶þÌìµÚÒ»Î»ÌØÑû±¨¸æ¼Î±ö¡¢Öйú¿ÆÑ§ÔºÒÅ´«Óë·¢ÓýÉúÎïѧÑо¿ËùµÄÍõÐã½ÜÑо¿Ô±Îª´ó¼Ò´øÀ´µÄÊÇÌâΪ¡¶m6A RNA modification: mechanism, function and social implications¡·µÄ¾«²Ê±¨¸æ¡£²ûÊöÁËm6AÐÞÊÎλµãµÄÑ¡ÔñÐÔͨ¹ý²âÐòÅä¶ÔÓÉmiRNAµ÷½Ú£¬½ÒʾÁËmiRNAÔÚµ÷½ÚmRNA±í¹ÛÒÅ´«ÐÞÊÎÖеÄй¦ÄÜ¡£´ËÍ⣬»¹½éÉÜÁËm6AÐÞÊÎÔÚµ÷½ÚСÊóСÄÔ·¢ÓýºÍ¹¦ÄÜÖеŦÄÜ¡£


Öйú¿ÆÑ§ÔºÉϺ£Ö²ÎïÄæ¾³ÉúÎïѧÑо¿ÖÐÐÄ
ÕÅÞ¿Ñо¿Ô±

Öйú¿ÆÑ§ÔºÉϺ£Ö²ÎïÄæ¾³ÉúÎïѧÑо¿ÖÐÐÄÕÅÞ¿Ñо¿Ô±×÷Ϊ±¾½ì´ó»áΨһһλ´ÓÊÂÖ²Îï·½ÃæÑо¿µÄ¼Î±ö£¬¸ø´ó¼Ò´øÀ´Á˹ØÓÚÖ²ÎïÖÐRNAÖ¸µ¼µÄDNA¼×»ù»¯µÄרÌⱨ¸æ¡£ÕÅÞ¿²©Ê¿Ê×Ïȼòµ¥½éÉÜÁËRNAÖ¸µ¼µÄDNA¼×»ù»¯£¨RdDM£©ÔÚÖ²ÎïÉúÎï¹ý³ÌÖеŦÄÜ×÷ÓᣲûÊöÁË»ùÓÚ±¨¸æ»ùÒòµÄÒÅ´«É¸Ñ¡ÏµÍ³ÈçºÎÈ·¶¨ÓëRNA¾ÛºÏøIVºÍV£¨RdDMµÄºËÐijɷ֣©¹¦ÄÜÏ໥×÷ÓõÄÒò×Ó¡£×îºóÏêϸ½ÒʾÁËÕâЩÒò×Óµ÷½Úpol IVºÍpol V¹¦ÄܵĿÉÄÜ»úÖÆ¡£


Öйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿ËùºÎ˳ÃñÑо¿Ô±

Öйú¿ÆÑ§ÔºÉúÎïÎïÀíÑо¿ËùºÎ˳ÃñÑо¿Ô±×÷ÁË¡¶6mA-DNA-binding factor Jumu controls maternal-to-zygotic transition upstream of Zelda¡·µÄרÌⱨ¸æ¡£Ö¸³öÅßÌ¥·¢ÉúÁìÓòµÄÒ»¸ö³¤ÆÚ´æÔÚµÄÎÊÌâÊÇ£ººÏ×Ó»ùÒò×éÈçºÎ±»Ä¸ÌåÒò×Ó¾«È·¼¤»î£¬´Ó¶øÔÊÐíÕý³£µÄÔçÆÚÅßÌ¥·¢Óý¡£±¨¸æÁËFox¼Ò×åµ°°×ÖÊJumu½áºÏ6mA±ê¼ÇµÄDNA²¢ÇÒ×÷Ϊµ÷½ÚĸÌå-ºÏ×Óת±äµÄĸÌåÒò×Ó¡£²ûÊöÁËzelda±àÂëµÄÏÈ·æÒò×ÓZelda±»6 mA±ê¼Ç£¬²¢ÇÒJumuͨ¹ýµ÷½ÚzeldaµÄ±í´ï£¬ÖÁÉÙÔÚÒ»¶¨³Ì¶ÈÉÏ¿ØÖÆÁËÔçÆÚÅßÌ¥ÖÐÊʵ±µÄºÏ×Ó»ùÒò×鼤»î£¨ZGA£©¡£´Ó¶ø½ÒʾÁËJumuÔÚÔçÆÚÅßÌ¥ÖÐͨ¹ýZelda²¿·Öµ÷½ÚZGAµÄ»úÖÆ¡£


Öйú¿ÆÑ§Ôº±±¾©»ùÒò×éÑо¿ËùËﱦ·¢Ñо¿Ô±

Öйú¿ÆÑ§Ôº±±¾©»ùÒò×éÑо¿ËùËﱦ·¢Ñо¿Ô±¸ø´ó¼Ò´øÀ´µÄÊǹØÓÚ¡¶Gene expression regulation by RNA Methylation¡·µÄרÌⱨ¸æ¡£Ê×Ïȼòµ¥½éÉÜÁËÁ½ÖÖmRNA·Ö×ÓÉÏ×î³£¼ûÇҷḻµÄÄÚ²¿ÐÞÊΣºm6AºÍm5C£¬²ûÊöÁËRNAÐÞÊÎÔÚ»ùÒò±í´ï¿ØÖÆÖеÄÖØÒª×÷Ó᣽ÒʾÁËm6AÔÚmRNA·­Òë¡¢¾«Ô­Ï¸°û·Ö»¯¡¢ÔìѪ¸Éϸ°ûºÍ×æÏ¸°ûÌØ»¯Öв»¿É»òȱµÄ×÷Óã¬ÒÔ¼°m5C´Ù½ømRNAµÄÊä³ö¡£×îºóÌÖÂÛÁËRNAÐÞÊεÄ×îнøÕ¹¼°ÆäDZÔÚµÄÉúÎïѧÒâÒå¡£


Cell Research¸ß¼¶Ö÷±àÁõÏþÀÙ²©Ê¿

Cell Research¸ß¼¶Ö÷±àÁõÏþÀÙ²©Ê¿Ê×Ïȸø´ó¼Ò½éÉÜÁËCell ResearchÆÚ¿¯µÄ¶¨Î»¡¢°æÃæ¡¢·Ö¹¤Çé¿öµÈ£¬Öصã½éÉÜÁËCell ResearchÊÇÈçºÎ´¦ÀíͶ¸åÎÄյ쬲¢½áºÏÆä¶àÄêµÄÉó¸å¾­Ñé·ÖÏíÁËCell ResearchµÄÉó¸åÁ÷³Ì¼°Æä×¢ÒâÊÂÏîµÈ£¬¸ø²Î»áÕßÌṩÁËһЩͶ¸å¼°ºóÆÚÈóÉ«µÄ½¨Ò飬¶ÔÓÚ¼´½«Òª·¢±í¿ÆÑ§ÂÛÎĵIJλáÕßÀ´Ëµ¿ÉνÊǸɻîÂúÂú¡£


ÖÐɽ´óÑ§Âæ¹ÛÕý½ÌÊÚ

ÖÐɽ´óÑ§Âæ¹ÛÕý½ÌÊÚΪ´ó¼Ò´øÀ´ÁËN6¼×»ùÏÙàÑßʵľ«×¼¼ì²âºÍ¹¦ÄÜÑо¿µÄרÌⱨ¸æ¡£Õë¶ÔĿǰm6AµÄ¼ì²â»ù±¾ÒÀÀµÓÚÃâÒß¹²³Áµí¼¼Êõ£¬Êý¾ÝµÄÖÊÁ¿ºÍ¿ÉÖØ¸´ÐÔÄÑÒԵõ½±£Ö¤µÄÎÊÌâ£¬Âæ½ÌÊÚ½éÉÜÁËÆä¿ÎÌâ×鿪·¢·¢ÐÂÐÍm6A¼ì²â¼¼Êõ£¬²¢Óë¸ßͨÁ¿²âÐòºÍ¶à×éѧ·ÖÎö½áºÏ£¬ÒÔÇóÔÚ¸ü¼Ó¾«×¼µÄǰÌáÏÂÈ¥Ñо¿m6AµÄ×÷ÓûúÖÆºÍÉúÎïѧ¹¦ÄÜ¡£


Î人´óѧҽѧÑо¿ÔºÐ¤ÈñÑо¿Ô±

Î人´óѧҽѧÑо¿ÔºÐ¤ÈñÑо¿Ô±ÔÚ´ó»á±¨¸æÖнéÉÜÁËÆä×îеÄÖØ°õÑо¿£¬Ê×ÏȽéÉÜÁËRBp¹ã·º´æÔÚÓÚÈËÀà»ùÒò×éÖлîÔ¾µÄȾɫÖÊÇøÓò£¬²¢ÇÒÓëת¼Òò×Ó£¨TFs£©Ö®¼ä´æÔÚ׏㷺µÄÏ໥¹ØÏµ£¬²¢¾ÙÀý˵Ã÷£ºRBM25£¨²ÎÓë¼ô½Óµ÷½ÚµÄRBp£©µÄȱʧ¼õÈõÁËËùÓÐYY1£¨ÒÑÖªµÄRNAÒÀÀµÐÔTFs£©ÒÀÀµÐÔ»îÐÔ£¬°üÀ¨È¾É«ÖʽáºÏ¡¢DNA»·»¯ºÍת¼¡£½ÒʾÁËRBps¿ÉÒÔͨ¹ýµ÷½ÚRNAÀ´¿ØÖÆ×ªÂ¼,´Ó¶øÔöÇ¿ÍøÂçµÄÏ໥×÷Óá£


ËÕÖÝ´óѧÀîÑîÐÀ½ÌÊÚ

ËÕÖÝ´óѧÀîÑîÐÀ½ÌÊÚΪ´ó¼Ò´øÀ´ÁË¡¶Ë¿ËØË®Äý½º°ü¹üµÄÍâÃÚÌåµÝËÍmiR-675¸ÄÉÆÐ¡ÊóºóÍÈѪ¹Ü¹¦ÄÜÕϰ­¡·µÄרÌⱨ¸æ¡£Àî½ÌÊÚ½éÉÜÁËÆäʵÑéÊÒ¿ª·¢µÄ»ùÓÚÍâÃÚÌåµÄÖÎÁÆ·½·¨ÒÔÒÖÖÆË¥ÀÏÒý·¢µÄѪ¹Ü²¡±ä¡£²ûÊöÁËÉÏÓηÖ×ÓmiR-675ÔÚµ÷¿ØÏ¸°ûË¥ÀÏÖз¢»ÓµÄÖØÒª×÷Ó㬴Ӷø½ÒʾÁËË¥ÀÏÓÕµ¼µÄѪ¹Ü¹¦ÄÜÕϰ­·Ö×Ó»úÖÆ¡£×îºó֤ʵÁËË¿ËØË®Äý½º°ü·âÍâÃÚÌåµÄ²ßÂÔΪÖÎÁÆË¥ÀÏÓÕµ¼µÄѪ¹Ü¹¦ÄÜÕϰ­¿ª±ÙÁËÒ»¸öеÄ;¾¶¡£


ÖÐɽ´óѧÉúÃü¿ÆÑ§Ñ§ÔºÑ»ª½ÌÊÚ

ÖÐɽ´óѧÉúÃü¿ÆÑ§Ñ§ÔºÑ»ª½ÌÊÚÔÚ´ó»á±¨¸æÖÐ×÷ÁË¡¶»ùÓÚ±í¹Ûת¼×éºÍ±í¹Û»ùÒò×éÊý¾Ý½âÎö×éµ°°×ÐÞÊÎÖ¸µ¼m6AÐÞÊÎÉú³ÉµÄµ÷¿Ø»úÖÆ¡·µÄ¾«²Ê±¨¸æ¡£Ñî½ÌÊÚ½éÉÜÁËÆä¿ÎÌâ×鿪·¢µÄһϵÁдӱí¹Û»ùÒò×éºÍ±í¹Ûת¼×éѧÊý¾Ý½âÎöm6A¼×»ù»¯µ÷¿ØµÄ¼ÆËã·½·¨£¬²¢²ûÊöÁËH3K36me3×÷Ϊת¼ÑÓ³¤µÄ±ê¼ÇÈ«ÃæÖ¸µ¼m6AÔÚmRNAÉϳÁ»ýµÄ»úÖÆ¡£ËµÃ÷ÁËÐÞÊεÄ×éµ°°×ºÍRNA¼×»ù»¯Ö®¼äµÄÏ໥×÷Óôú±íÁËÒ»ÖÖеĵ÷½Ú²ãÃæ¡£

¼¯Ìå½»Á÷»·½Ú


ÌÖÂÛÈÈÁҵļαö¼¯Ìå½»Á÷»·½Ú



²Î»á´ú±íÃÇ·×·×Ó»Ô¾ÌáÎÊ ÏÖ³¡Æø·Õ·Ç³£ÈÈÁÒ

±¾½ì´ó»áµÄ¼Î±ö¼¯Ìå½»Á÷»·½ÚÖ¼ÔÚÈòλáÕßÃÇͬ±¾½ì¼Î±ö½øÐиüÉî¶ÈµØ½»Á÷»¥¶¯¡£ÔÚÕâ¸ö»·½ÚÖУ¬²Î»áÕßÃÇ·×·×Î§ÈÆ¿ÎÌâ»òʵÑéÖÐÓöµ½µÄÀ§»ó¡¢ÊµÑéÎÊÌâµÈ½øÐÐÌáÎÊ£¬µÃµ½¼Î±öµÄÈÈÇé½â´ðºÍÕæÖª×Æ¼û£¬¼¤ÁÒ˼ÏëÅöײÈôó¼ÒÉîÊÜÆô·¢¡£

²Î¹ÛÈñ²©ÉúÎï


²Î¹ÛÈñ²©ÉúÎïÈËÔ±¼¯ÌåºÏÓ°

µÚÒ»Ìì»áÒéÈճ̽áÊøºó£¬²¿·Ö¼Î±ö¼°²Î»áÕ߲ιÛÁËÈñ²©ÉúÎï×ܲ¿£¬Öصã²Î¹ÛÁ˹«Ë¾Õ¹Ìü¡¢¿ÆÑÐʵÑéÊÒºÍcGMpºËËáÉú²ú³µ¼ä£¬²Î¹ÛÈËÔ±·×·×¶ÔÈñ²©ÉúÎïÔÚºËËἰϸ°ûÉúÎïѧ·½ÃæµÄÁìÏÈÑз¢ÊµÁ¦±íʾ³ÆÔÞ£¬Èñ²©ÉúÎï¹ú¼ÊÒ»Á÷µÄºËËá¿Æ¼¼²úҵƽ̨ºÍ¡°´´ÐÂÓÀ²»Í£¡°µÄ¾«Éñ¸øÀ´±öÃÇÁôÏÂÉî¿ÌÓ¡Ï󣬶øÈñ²©ÉúÎïλÓÚ¹ãÖÝ¿ª·¢ÇøµÄлùµØÒ²½«ÓÚ½ñÄêÂä³ÉͶ²ú£¬Åú´Î²úÄܽ«´ïµ½20¹«½ï¼¶ÒÔÉÏ£¬½ìʱ½«³ÉΪÑÇÖÞ¹æÄ£×î´óµÄ¹ÑºËËáÔ­ÁÏÒ©Éú²ú»ùµØ¡£

ͬʱ£¬Èñ²©ÉúÎﻹ½«¼ÌÐøÖÂÁ¦ÓÚ¡°´Ù½øÑ§Êõ½»Á÷£¬¹²ÍÆÑо¿·¢Õ¹¡±µÄ³ç¸ßʹÃü£¬²»¶ÏΪÖйú·Ç±àÂëRNA¡¢±í¹ÛÒÅ´«Ñ§¡¢ºËËá¿Æ¼¼Ò½Ñ§×ª»¯¼°²úÒµ»¯¹±Ï×Ò»·ÝÖØÒªÁ¦Á¿£¬»ý¼«²ÎÓë´î½¨ÖйúºËËá¹ú¼ÊÂÛ̳£¨CNAF£©ºÍ·Ç±àÂëRNAÓë±í¹ÛÒÅ´«Ñ§Ñо¿½»Á÷»áµÄÕâÑù¾ßÓÐÖØÒªÐÐÒµÓ°ÏìÁ¦µÄƽ̨£¬½ñÄêϰëÄêµÄ11ÔÂ7ÈÕ-8ÈÕ½«¾Ù°ìµÚÆß½ìÖйúºËËá¹ú¼ÊÂÛ̳£¬ÆÚ´ý¼ÌÐøÐ¯ÊÖ°üÀ¨¶àλŵ±´¶û½±µÃÖ÷ÔÚÄڵĹú¼Ê´ó¿§Óë¶¥¼¶¿ÆÑ§¼ÒÃǹ²ÏåÊ¢¾Ù£¡